NeuraPlus Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

NeuraPlus General Information

Description

Developer of non-invasive neuromodulation and bioelectronic medicine and devices intended for neurorehabilitation and cognitive disorder intervention in clinical research. The company is actively developing non-invasive neuromodulation system, brain-computer interface, smart wearable, mobile medical devices, and the company has developed a portable transcranial electrical stimulation training device, enabling patients with brain disease to obtain an effective treatment solutions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 302, Building C1, China Merchants Guangming Technology Park, Fenghuang Street
  • Guangming District
  • Shenzhen, Guangdong 518055
  • China
+86 0755
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • Room 302, Building C1, China Merchants Guangming Technology Park, Fenghuang Street
  • Guangming District
  • Shenzhen, Guangdong 518055
  • China
+86 0755

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuraPlus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 25-Nov-2024 Completed Generating Revenue
3. Later Stage VC 21-Jun-2024 Completed Generating Revenue
2. Later Stage VC 11-Aug-2023 Completed Generating Revenue
1. Early Stage VC 22-Sep-2022 Completed Generating Revenue
To view NeuraPlus’s complete valuation and funding history, request access »

NeuraPlus Patents

NeuraPlus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025260523-A1 Electrode positioning system based on personalized brain segmentation Pending 20-Jun-2024
WO-2025162104-A1 Electroencephalogram signal-based awakening method and apparatus for coma patient, electronic device, and storage medium Pending 31-Jan-2024

NeuraPlus Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Daohe Long Term Investment Management Growth/Expansion Minority
Seven Seas Partners (China) Venture Capital Minority
Shenzhen Zhongke Scientific Technological Equity Investment Fund Management Growth/Expansion Minority
TigerYeah Capital Venture Capital Minority
To view NeuraPlus’s complete investors history, request access »

NeuraPlus FAQs

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process